top of page
The Professional Network for Healthcare Experts
Lupin receives Indian marketing approval for pegfilgrastim biosimilar
Lupin has received Indian marketing approval for a pegfilgrastim biosimilar used to reduce the risk of chemotherapy-induced neutropenia.
nuaxia
Sep 111 min read
Japan approves Biocon Biologics’ pegfilgrastim biosimilar for cancer supportive care
The MHLW marketing approval adds a Neulasta biosimilar to Biocon’s Japanese portfolio, with Sandoz K.K. responsible for its exclusive promotion, sale and distribution in the country.
nuaxia
Aug 252 min read
bottom of page